Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Collect feedback from your transactions and adjust categories or goals accordingly. Small, data-driven changes lead to meaningful improvements.
20,099 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
A payments stock down draws 30% on growth concerns while a small investor places a $6 million bet as revenue hits $4 ...
Investors are debating whether Microsoft stock is undervalued. This guide breaks down the fundamentals, growth cataly...
A high-stakes portfolio shuffle by a famed activist investor grabbed headlines. This piece breaks down what happened,...
XRP has repeatedly rebounded despite jitters in the crypto space. This article uncovers the real reason keeps bouncin...
A spike in pandemic-era scams swore of fast wealth, but the reality was a carefully hidden pyramid scheme. Learn how ...
A message that seems to come from the boss can trigger a chain of costly actions. This guide breaks down how these sc...
Buffett's latest caution mirrors his Dot-Com-era warnings. In a market buzzing with hype, where does prudence fit in?...
A trio of durable cash-flow stocks offer steady dividends and room to grow, giving investors a balanced path through ...
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
In March 2026, a disciplined approach to income investing means looking for companies with a proven track record of r...
When Road releases its Q2 results, the transcript hides clues about growth and risk. This guide translates the road 2...